Abderrazzak Merzouki
Chief Tech/Sci/R&D Officer at SUNSHINE BIOPHARMA, INC.
Net worth: 7 003 $ as of 2024-03-30
Profile
Abderrazzak Merzouki is currently the Chief Science Officer & Director at Sunshine Biopharma, Inc. since 2016.
He is also currently a Senior Scientist at Imperial College London since 2007.
Previously, he worked as the Director-Cell Engineering & Biotherapeutics at Hydrogen Future Corp.
Dr. Merzouki holds a graduate and doctorate degree from the University of Quebec and a doctorate degree from Institut Armand-Frappier.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-27 | 116,720 ( 0.12% ) | 7 003 $ | 2024-03-30 |
Abderrazzak Merzouki active positions
| Companies | Position | Start |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 2024-01-24 |
| Imperial College London | Corporate Officer/Principal | 2011-02-03 |
Former positions of Abderrazzak Merzouki
| Companies | Position | End |
|---|---|---|
| HYDROGEN FUTURE CORP | Corporate Officer/Principal | - |
Training of Abderrazzak Merzouki
| University of Quebec | Doctorate Degree |
| Institut Armand-Frappier | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SUNSHINE BIOPHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Hydrogen Future Corp.
 Hydrogen Future Corp. Agricultural Commodities/MillingProcess Industries Hydrogen Future Corp. operates as a holding company. The firm engages in the provision of contract research and laboratory services. It provides alternate energy generation products and services. The company was founded on June 21, 2006 and is headquartered in Houston, TX. | Process Industries |
- Stock Market
- Insiders
- Abderrazzak Merzouki
